Changes in cellular contractility and cytokines profile during Trypanosoma cruzi infection in mice
- PMID: 19190953
- DOI: 10.1007/s00395-009-0776-x
Changes in cellular contractility and cytokines profile during Trypanosoma cruzi infection in mice
Abstract
Trypanosoma cruzi, an intracellular protozoan parasite infecting a wide variety of vertebrates, is the agent responsible for Chagas' disease. This pathology often results in severe inflammatory heart condition and it is one of the major causes of dilated cardiomyopathy leading to heart failure in Latin America. Nevertheless, little is known about the changes in isolate cardiac myocytes contractility during the development of this pathology. Here we report a relationship between cytokines profile of mice infected with T. cruzi and the modifications in the cellular contractility pattern. We found that cellular contractility, measured as fractional shortening, showed a complex behavior. The changes were evaluated during the acute phase (15, 30 and 45 dpi) and chronic phase (>90 dpi). The time to half contraction and relaxation were lengthier despite the number of days after infection or the heart region evaluated. The maximal contraction and relaxation velocities were significantly slower. The observed changes in cellular contractility were correlated with the presence of circulating IFN-gamma, TNF-alpha and MCP-1/CCL2 during the course of infection. Together, our data demonstrate that cellular contractility is altered in the three heart regions studied, and these alterations are observed at the very beginning of the parasitism and they remained until the chronic phase has been reached. Indeed, we propose a role for IFN-gamma, TNF-alpha and MCP-1/CCL2 in the mechanical heart remodeling during experimental Chagas' disease.
Similar articles
-
Novel insights into the development of chagasic cardiomyopathy: role of PI3Kinase/NO axis.Int J Cardiol. 2013 Sep 10;167(6):3011-20. doi: 10.1016/j.ijcard.2012.09.020. Epub 2012 Sep 29. Int J Cardiol. 2013. PMID: 23031286
-
Myocardial gene and protein expression profiles after autoimmune injury in Chagas' disease cardiomyopathy.Autoimmun Rev. 2011 Jan;10(3):163-5. doi: 10.1016/j.autrev.2010.09.019. Epub 2010 Sep 29. Autoimmun Rev. 2011. PMID: 20883825 Review.
-
Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease.Parasite Immunol. 2010 Mar;32(3):202-8. doi: 10.1111/j.1365-3024.2009.01179.x. Parasite Immunol. 2010. PMID: 20398183
-
Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):405-13. doi: 10.1016/j.cytogfr.2008.08.002. Epub 2008 Oct 19. Cytokine Growth Factor Rev. 2008. PMID: 18938102 Review.
-
Distinct outcomes of Trypanosoma cruzi infection in hamsters are related to myocardial parasitism, cytokine/chemokine gene expression, and protein expression profile.J Infect Dis. 2008 Aug 15;198(4):614-23. doi: 10.1086/590347. J Infect Dis. 2008. PMID: 18598198
Cited by
-
Arrhythmogenic Manifestations of Chagas Disease: Perspectives From the Bench to Bedside.Circ Res. 2024 May 10;134(10):1379-1397. doi: 10.1161/CIRCRESAHA.124.324507. Epub 2024 May 9. Circ Res. 2024. PMID: 38723031 Free PMC article. Review.
-
Shenfu injection attenuates cardiac dysfunction and inhibits apoptosis in septic mice.Ann Transl Med. 2022 May;10(10):597. doi: 10.21037/atm-22-836. Ann Transl Med. 2022. PMID: 35722372 Free PMC article.
-
Impact of IFN-γ Deficiency on the Cardiomyocyte Function in the First Stage of Experimental Chagas Disease.Microorganisms. 2022 Jan 25;10(2):271. doi: 10.3390/microorganisms10020271. Microorganisms. 2022. PMID: 35208732 Free PMC article.
-
A novel substrate for arrhythmias in Chagas disease.PLoS Negl Trop Dis. 2021 Jun 2;15(6):e0009421. doi: 10.1371/journal.pntd.0009421. eCollection 2021 Jun. PLoS Negl Trop Dis. 2021. PMID: 34077437 Free PMC article.
-
IL-10-Dependent and -Independent Mechanisms Are Involved in the Cardiac Pathology Modulation Mediated by Fenofibrate in an Experimental Model of Chagas Heart Disease.Front Immunol. 2020 Sep 24;11:572178. doi: 10.3389/fimmu.2020.572178. eCollection 2020. Front Immunol. 2020. PMID: 33072115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous